Drugs / Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A
last change Apr 2010 re-read 3 minutes ago

Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A

Vaccine

Developed for
influenza
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00944073 Aug 2009 → Apr 2010 influenza National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Influenza Virus Vaccine, Monovalent A/H1N1 A/California/7/2009 NYMC X-179A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00944073 ↗
Modality Vaccine “inactivated influenza H1N1 vaccine” NCT00944073 ↗
Route Intramuscular “delivered intramuscularly” NCT00944073 ↗